Omega-3 fatty acids ameliorate proteinuria but not renal function in iga nephropathy: A meta-analysis of randomized controlled trials

Hsin Hsu Chou, Yuan Yow Chiou, Peir Haur Hung, Pei Chung Chiang, Shan Tair Wang

Research output: Contribution to journalArticlepeer-review

18 Citations (Scopus)

Abstract

Background/Aim: The effects of ω-3 fatty acids (O3FAs) on renal function and proteinuria in immunoglobulin A nephropathy (IgAN) are not fully understood. Thus, we conducted an up-to-date meta-analysis of the currently available randomized controlled trials (RCTs) to validate the effects of O3FA in IgAN. Methods: A literature search was performed in PubMed, Medline, Embase and the Cochrane Central Registry of Controlled Trials using an extended search strategy to identify RCTs that assessed the treatment efficacy of O3FA in IgAN. The dose-effect relationships of O3FA on renal function and proteinuria were also determined. Results: Five RCTs with a total of 233 patients were included in our analysis. Our results demonstrated that while O3FA does not have any beneficial effects in preserving renal function in IgAN, proteinuria was significantly reduced. Furthermore, patients who received a high dose of O3FA (>3 g/day) did not differ from those who received a low dose of O3FA (≤3 g/day) in renal function or proteinuria. Conclusion: The currently available evidence suggests that O3FA has no benefit in preserving renal function, but can ameliorate proteinuria in IgAN. However, the effects of O3FA on proteinuria are not dose dependent.

Original languageEnglish
Pages (from-to)c30-c35
JournalNephron - Clinical Practice
Volume121
Issue number1-2
DOIs
Publication statusPublished - 2012 Dec 1

All Science Journal Classification (ASJC) codes

  • Nephrology

Fingerprint Dive into the research topics of 'Omega-3 fatty acids ameliorate proteinuria but not renal function in iga nephropathy: A meta-analysis of randomized controlled trials'. Together they form a unique fingerprint.

Cite this